ストックスクリーナーアプリを入手
3.21
0.31%
-0.01
アフターアワーズ：
3.21
Anavex Life Sciences Corp (AVXL) 最新ニュース
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com India
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - The Manila Times
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex urges shareholders to back board slate amid proxy fight - Investing.com
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders - The Manila Times
Anavex Life Sciences Files Definitive Proxy Statement and Urges Stockholders to Vote for All Six Director Nominees on WHITE Card - Quiver Quantitative
Anavex Life Sciences Corp Solicits Proxies from Shareholders - marketscreener.com
Anavex Life Sciences (NASDAQ:AVXL) Stock Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Anavex Life Sciences (NASDAQ: AVXL) delays two 2026 quarterly SEC reports - Stock Titan
Anavex Life Sciences Corp (AVXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVXL Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Anavex Life Sciences Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech - DirectorsTalk Interviews
Anavex Life Sciences Corp. Revenue Breakdown – NASDAQ:AVXL - TradingView
Anavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine Media
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - anavex.com
Press Release: Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - moomoo.com
Weekly Recap: IND filing for blarcamesine and Q2 loss, cash runway - TradingView
[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock Titan
Vanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - king5.com
Anavex Life Sciences (NASDAQ:AVXL) Releases Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anavex Life Sciences Corp (AVXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anavex Life Sciences Corp (AVXL) Balance Sheet - TradingKey
Anavex Life Sciences Corp (AVXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVXL|Anavex Life Sciences Corp|Price:2.400|Chg%:-0.080 - TradingKey
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anavex Life Sciences Corp (AVXL) Income Statement - TradingKey
AVXL|Anavex Life Sciences Corp|Price:2.532|Chg%:+0.032 - TradingKey
Anavex Life Sciences Corp. Revenue Breakdown – SWB:12X1 - TradingView
TradingKey - TradingKey
PVG targets full board replacement at Anavex Life Sciences (NASDAQ: AVXL) - Stock Titan
Trading Systems Reacting to (AVXL) Volatility - Stock Traders Daily
Anavex Submits Nasdaq Compliance Plan After Filing Delay - The Globe and Mail
Anavex Life Sciences Submits Plan to Regain Compliance With Nasdaq Timely Filing Rule - marketscreener.com
Anavex Life Sciences submits compliance plan to Nasdaq after 10-Q delay - TradingView
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Axel Paeger Net Worth (2026) - GuruFocus
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
AVXL Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Second Circuit Holds that Delayed, Market-Tracking Stock Drop Dooms Loss Causation - Jones Day
Anavex Life Sciences (AVXL) Jumps 6.98% as Biotech Rally Tests Key Resistance at $2.90TRIN Signal - dars.gov.et
Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks - Sahm
CEO transition and delayed SEC filing put Anavex (AVXL) leadership changes in focus - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
How Anavex Life Sciences Corp. (AVXL) Affects Rotational Strategy Timing - Stock Traders Daily
Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewir - The National Law Review
Anavex Life Sciences Corp.(NasdaqGS: AVXL) added to Russell 2000 Value Benchmark - marketscreener.com
Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anavex Life Sciences: Waiting On Validation As Blarcamesine Shows Some Promise - Seeking Alpha
AVXL Forecast — Price Target — Prediction for 2027 - TradingView
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):